Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya
10.1186/s12936-022-04284-6 · doi-reference
Brief antibiotic use drives human gut bacteria towards low-cost resistance
10.1038/s41586-025-08781-x · doi-reference
Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum
10.1038/nature00813 · doi-reference
Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: a modelling study
10.1371/journal.pmed.1002416 · doi-reference
The development and spread of drug-resistant malaria
10.1016/0169-4758(91)90262-m · doi-reference
Genetic surveillance of Plasmodium falciparum populations following treatment policy revisions in the Greater Mekong Subregion
10.1038/s41467-025-59946-1 · doi-reference
Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative study
10.1016/s1473-3099(20)30149-3 · doi-reference
Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China
10.4269/ajtmh.2005.72.410 · doi-reference
The industrial melanism mutation in British peppered moths is a transposable element
10.1038/nature17951 · doi-reference
The impact of sulfadoxine–pyrimethamine resistance on the effectiveness of intermittent preventive treatment for the prevention of malaria in pregnancy in Africa: an updated systematic review and meta-analysis
10.1016/s1473-3099(25)00219-1 · doi-reference
Decreased colistin resistance and mcr-1 prevalence in pig-derived Escherichia coli in Japan after banning colistin as a feed additive
10.1016/j.jgar.2021.01.016 · doi-reference
Intrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand
10.1086/509809 · doi-reference
10.1101/2024.06.03.597162
10.1101/2024.06.03.597162 · doi-reference
Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase
10.1073/pnas.90.12.5653 · doi-reference
Fluoroquinolone stewardship at a community health system: a decade in review
10.1017/ash.2022.326 · doi-reference
Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use
10.1093/jac/dkp387 · doi-reference
Dynamics of mcr-1 prevalence and mcr-1-positive Escherichia coli after the cessation of colistin use as a feed additive for animals in China: a prospective cross-sectional and whole genome sequencing-based molecular epidemiological study
10.1016/s2666-5247(20)30005-7 · doi-reference
The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland
10.1056/nejm199708143370701 · doi-reference
The effect of antibiotic restriction programs on prevalence of antimicrobial resistance: a systematic review and meta-analysis
10.1093/ofid/ofab070 · doi-reference
Longitudinal trends of HIV drug resistance in a large Canadian cohort, 1996–2016
10.1016/j.cmi.2017.06.014 · doi-reference
Longitudinal study on the occurrence in pigs of colistin-resistant Escherichia coli carrying mcr-1 following the cessation of use of colistin
10.1111/jam.13907 · doi-reference
10.21203/rs.3.rs-2072289/v1
10.21203/rs.3.rs-2072289/v1 · doi-reference
A SYBR green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs
10.1186/1475-2875-12-450 · doi-reference
Trends in infection incidence and antimicrobial resistance in the US veterans affairs healthcare system: a nationwide retrospective cohort study (2007–22)
10.1016/s1473-3099(24)00416-x · doi-reference
Explaining the stable coexistence of drug-resistant and -susceptible pathogens: the resistance acquisition purifying selection model
10.1016/j.epidem.2025.100848 · doi-reference
Adaptive evolution of malaria parasites in French guiana: reversal of chloroquine resistance by acquisition of a mutation in pfcrt
10.1073/pnas.1507142112 · doi-reference
In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine
10.1128/jvi.02154-08 · doi-reference
Nonadherence in Tuberculosis treatment: predictors and consequences in New York city
10.1016/s0002-9343(96)00402-0 · doi-reference
Trends in drug-resistant Mycobacterium tuberculosis in New York city, 1991–2003
10.1086/504325 · doi-reference
Decreased prevalence of the Plasmodium falciparum Pfcrt K76T and Pfmdr1 and N86Y mutations post-chloroquine treatment withdrawal in Katete District, Eastern Zambia
10.1186/s12936-021-03859-z · doi-reference
Does directly observed therapy (DOT) reduce drug resistant tuberculosis?
10.1186/1471-2458-11-19 · doi-reference
